DGX
UNH

WILENSKY GAIL R

Known title: DirectorCIK: 0001018538

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus. Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.

this person other insiders at DGX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

UnitedHealth Q3 Margins Rise, Membership Declines, Stock Volatility. UnitedHealth Group reported that Q3 operating margins improved while membership numbers slipped, a mix that could reshape the company's growth outlook. The earnings beat sparked a sharp 51% drop followed by a 40% rebound, reflecting market uncertainty. Analysts note that guidance revisions this earnings season may influence future performance.

this person other insiders at UNH

Transaction History

DGX▲ Buy$0
DGX▲ Buy$0
UNH▲ Buy$0
UNH▲ Buy$0
UNH▲ Buy$0
UNH▲ Buy$0
UNH▲ Buy$0
UNH▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.